Technical Articles

Rheumatoid arthritis (RA) is a complex chronic autoimmune disease affecting approximately 0.5%-1% of the global population. RA not only causes joint inflammation and pain but also leads to various complications, significantly impacting patients' quality of life. In recent years, with a deeper understanding of the pathological mechanisms of RA, scientists have identified several key immunomodulatory target proteins, offering new possibilities for developing innovative treatment strategies.